HYPD - EYENOVIA, INC.

3.11
0.010   0.322%

Share volume: 79,782
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%
$3.10
0.01
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
21%
Profitability 25%
Dept financing 4%
Liquidity 50%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.32%
1 Month
-21.66%
3 Months
-16.40%
6 Months
-52.01%
1 Year
99.94%
2 Year
96.84%
Key data
Stock price
$3.11
P/E Ratio 
0.00
DAY RANGE
$2.98 - $3.11
EPS 
-$3.94
52 WEEK RANGE
$0.85 - $17.18
52 WEEK CHANGE
$99.94
MARKET CAP 
54.555 M
YIELD 
N/A
SHARES OUTSTANDING 
8.098 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
02-03-2025
NEXT EARNINGS DATE
04-29-2025
BETA 
2.23
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$261,805
AVERAGE 30 VOLUME 
$318,963
Company detail
CEO: Michael M. Rowe
Region: US
Website: eyenovia.com
Employees: 40
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Eyenovia, Inc. engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. Its product candidates include MicroLine, MicroPine and MydCombi.

Recent news